Skip to content
Lower risk Drug recall · FDA · Published June 30, 2025

Cipla Budesonide Inhaler Recall: Leakage Risk in Ampules

Cipla USA recalls 0.5mg/2ml Budesonide inhaler ampules due to leakage and empty ampoules. Stop using if you have the specific batch.

🇺🇸 FDA recall #D-0541-2025DrugCipla USA ›
Take action

Contact the company

Recalling firmCipla USA, Inc.10 Independence Blvd · Warren, NJ 07059-2730
✎ GovInfoNow plain-language explainer

Cipla USA is recalling Budesonide Inhalation Suspension ampules because they may leak or become empty. This could lead to improper medication delivery and potential health risks. Read more at govinfonow.com/recall/32005-cipla-budesonide-inhaler-recall-leakage-risk-in-ampules.

Source Summary by GovInfoNow · govinfonow.com/recall/32005-cipla-budesonide-inhaler-recall-leakage-risk-in-ampules · Updated August 17, 2026 · FDA enforcement record: FDA #D-0541-2025

Cite this page

“Cipla Budesonide Inhaler Recall: Leakage Risk in Ampules.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32005-cipla-budesonide-inhaler-recall-leakage-risk-in-ampules. Based on FDA recall #D-0541-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0541-2025%22&limit=1).

The FDA announced on June 30, 2025, that Cipla USA, Inc. is recalling Budesonide Inhalation Suspension due to a lack of assurance of sterility. The agency issued recall number D-0541-2025 for the drug distributed nationwide in the United States.

How to tell if you have it

  • Brand: Cipla USA
  • Product: Budesonide Inhalation Suspension, 0.5mg/2ml
  • Packaging: 30 single-dose ampules per carton, five per pouch
  • NDC#: 69097-319-86 (pouch), 69097-319-87 (carton)
  • Batch #: 4IA0505
  • Expiration: 09/31/2026

The hazard

The recall addresses a lack of assurance of sterility following a market complaint regarding leakage and an empty ampoule. The FDA classified the recall as Class II.

Context

GovInfoNow's records show Cipla USA, Inc. has had 12 other recalls on record since June 27, 2023. Other recent recalls of similar products include Cipla Cinacalcet Tablets Recall (June 29, 2026), Cipla Lanreotide Injection Recall (March 13, 2026), and Cipla Phytonadione Injectable Emulsion Recall (October 31, 2025).

How to tell if you have this one

Check for the NDC code 69097-319-86 (pouch) or 69097-319-87 (carton) and batch number 4IA0505. The product is sold in prescription-only packages.

  • Brand
    Cipla USA
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the NDC code 69097-319-86 (pouch) or 69097-319-87 (carton) and batch number 4IA0505.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Distributed Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 30 days after the firm started it.

1. Firm started the recall: Jun 30, 202512. FDA classified it Class II: Jul 22, 202523. Published in FDA’s Enforcement Report: Jul 30, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Cipla USA recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0541-2025 (June 30, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0541-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA